Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...

In the past 60 days, the Zacks Consensus Estimate for Arcturus’ 2024 loss per share has narrowed from $4.39 to $2.60. Also, the Zacks Consensus Estimate for 2025 has moved from a loss of 45 cents to ...

US mRNA-immunotherapy start-up Myeloid Therapeutics has launched Aurora Biosynthetics in Sydney to meet the Asia-Pacific ...

Cartesian Therapeutics has a strong cash position after a $130 million equity raise, extending its runway to support upcoming ...

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

As of 8:05 am GMT+2. Market open. China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they ...

Modified nucleotides like m5C in saRNA enhance vaccine efficacy, stability, and reduce inflammation, offering a promising ...

Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop COVID-19 vaccines and are now exploring their potential in other disease areas (Figure 1). The success ...

Aurora Biosynthetics, a pioneering RNA therapeutics manufacturer company, announced its official launch, ushering in a new ...

Novo Nordisk's deal with Korro is worth a total of $530 million in research and development (R&D) funding, milestone payments, royalties, and up-front payments to get the ball rolling. That makes the ...